Interestingly, treatment with an anti-HGF antibody reduced circulating Tregs among gastric cancer patients, highlighting the role of HGF in fostering Treg accumulation indirectly via c-MET-expressing monocytes. This evidence concerns the gene HGF and gastric cancer.